Why PE Is Paying 14x EBITDA for Mid-Market CPA Firms
Mid-market CPA firms are selling to PE at 11x to 15x EBITDA. The multiple is not about the book of business. It is about a binding operational constraint AI is breaking.
TL;DR. Mid-market CPA firms are selling to PE at 11x to 15x EBITDA, with Blackstone's January 2025 take of Citrin Cooperman at roughly 15x setting the new ceiling. The multiple is not about the book of business. It is about a binding partner-hour constraint that AI is the first credible tool to break. The firms that can collapse the partner-to-staff ratio from 1:8 to 1:14 will see 8 to 10 points of margin drop into EBITDA on the same revenue. PE knows the math. Most managing partners at $40-80M firms have not yet decided whether they want to be the platform, the tuck-in, or the firm that engineers the leverage ratio on its own balance sheet.
If you run operations at a $40-80M public accounting firm, you have either taken a call from a PE buyer in the last 18 months or you will take one in the next 12. The opening question is some version of "what's your EBITDA," and the closing question is some version of "would 14 times that interest you." That is the active deal flow.
The interesting question is not whether the multiple is real. It is what the buyer thinks they are buying.
The 14x is not random
The headline number comes from a small set of recent deals. In January 2025, Blackstone-led investors bought a majority stake in Citrin Cooperman from New Mountain Capital at a valuation of roughly $2 billion, the first PE-to-PE secondary in U.S. accounting. New Mountain had bought in at about 11x EBITDA in 2021 at a valuation near $500 million. Blackstone bought four years later at roughly 15x. Same firm. Same book of business. Four years of operating-leverage compression.
The Citrin Cooperman flip is not an outlier. The same band shows up across the 2022-2025 deal sheet. TowerBrook took EisnerAmper in 2021. Parthenon Capital took Cherry Bekaert in 2022. Charlesbank invested in Aprio in July 2024 at the firm's then-$420M revenue level. New Mountain took Grant Thornton's U.S. business in March 2024 in what trade press called the largest CPA transaction to date, until Hellman & Friedman backed the Baker Tilly and Moss Adams combination at a $7 billion valuation in April 2025. Centerbridge took Carr Riggs & Ingram in November 2024. Investcorp and PSP backed PKF O'Connor Davies the same month. Goldman Sachs Alternatives is closing on Schellman in the second quarter of 2026.
The deals all use the same structural workaround. State CPA ownership rules require attest work (audits, reviews, compilations) to live inside a partner-owned entity. So the firm splits. The attest practice (Cherry Bekaert LLP, Aprio LLP, Grant Thornton LLP) stays partner-owned and continues to sign audit opinions. A separate advisory and tax entity takes the PE capital. The two operate under a Management Services Agreement and share brand, people, and technology, but are legally distinct. The AICPA opened comment on tighter independence rules around this structure in December 2025; comment closed April 30, 2026. The structure works for now. It is the price of entry, not the thesis.
The thesis is the multiple. Pre-PE mid-market CPA firms trade at 4-6x EBITDA in traditional sales. Strong organic growth platforms reach 7-10x. PE-backed platform deals sit in the 11x to 15x band for high-quality $20M to $200M targets. PE is not paying for the book. They are paying for an operational delta they intend to engineer over the four-year hold.
The binding constraint is partner hours, not capital
The misread is that the constraint is talent, and PE money buys talent. Talent is a real constraint. It is not the binding one.
The binding constraint at $40-80M is the partner-hour bottleneck on signed deliverables. Every tax return of consequence, every audit opinion, every advisory memo that carries a partner's name requires partner review. With eight to twelve equity partners, the firm is structurally capped at the work product those partners can personally inspect inside roughly 2,200 billable hours each per year. PE money cannot buy more partner hours. It can buy more bodies to feed the existing partner-review queue. That makes the queue longer, not shorter.
This is why hiring more senior managers feels like the answer and is not. The shortage is real: the Bureau of Labor Statistics counted 340,000 net accountants exiting the field between 2019 and 2024, and the AICPA's 2024 Trends data showed the lowest number of new CPA exam candidates since NASBA began tracking in 2008. But adding senior managers without restructuring the review topology just moves the queue one node upstream. The firm still ships at partner throughput.
The firms that absorb PE capital and grow are the ones that have already broken the review topology. They have codified partner judgment into reviewable artifacts: standardized checklists, decision trees, exception flags, second-tier sign-off on specific deliverable categories. The firms that stall under PE ownership are the ones where every non-trivial deliverable still routes through the founding partners' inboxes. PE buyers have run this diligence enough times to price the difference. The 14x is what they pay for the firms that have done the work. The 9x is what the others get.
The two paths a $50M managing partner is actually choosing between
If you run a $40-80M firm, you have two live strategic paths in front of you right now. There is technically a third, but it is the honest option for a different reader.
Path A: Take the capital and become the platform. Fits firms with 12+ partners, $60M+ revenue, a managing partner under 55, and a clear number two already operating like a COO. You take PE money, tuck in four to six smaller firms over 36 months, exit at year four to a larger platform or continuation fund. The binding constraint inside this path is not deal flow. It is integration capacity. Every tuck-in firm arrives with its own partner-review topology, and you inherit the worst of theirs. Citrin Cooperman closed sixteen acquisitions during New Mountain's four-year hold. The integration math is what made the 11x-to-15x expansion possible. The firms that fail this path do so on integration, not deal sourcing.
Path B: Stay independent, engineer the leverage ratio, sell later at a higher multiple. Fits firms with 6-10 partners, $40-60M revenue, a managing partner who still enjoys the work, and a partner group aligned on a 3-5 year horizon. The binding constraint is internal alignment. Can the partners agree to standardize their own review work enough for it to be templated, instrumented, and partially automated? If yes, you walk into 2029 with a 1:14 partner-to-staff ratio, 35%+ EBITDA margins, and you are the platform PE wants to buy at the top of its multiple range. If no, you sell in 2027 at today's multiple minus 18 months of distraction.
The honest third option is a sale to an existing platform now, for firms with 4-7 partners, succession gaps, and founding partners 60+. The earn-out is straightforward, two or three partner departures happen in the first 18 months, and the founders are quieter than they expected. Legitimate choice, different conversation.
Paths A and B are the conversation worth having now. The decision is not about appetite for capital. It is about which binding constraint your partner group can actually move first.
The AI-leverage math that justifies the multiple
A typical mid-market CPA firm in 2026 runs at roughly 1 partner per 8 staff, $1.4M revenue per partner, and 22% to 26% EBITDA margins. The 14x multiple assumes the acquirer can drive that to 1:14, $2.2M per partner, and 34% to 38% EBITDA inside 36 months. Partner comp is roughly 30% of operating cost. Collapse the partner-to-staff ratio by 40%, hold revenue, and 8 to 10 points of margin drop straight to EBITDA. On $50M of revenue that is the difference between $12M and $18M of EBITDA. PE is not paying 14x the book. They are paying 7x the book plus 14x the operational delta they intend to engineer.
This is where AI stops being a feature and becomes the entire deal thesis. Three tools are doing the work.
DataSnipper has crossed 600,000 audit professionals globally and is standard at all Big 4 and most of the IPA top 100. Grant Thornton publicly reported reducing one invoice-testing engagement from 600 hours to 30. The tool extracts data from PDFs into Excel and ties workpaper references back to source. It collapses one specific category of senior-associate work and pushes review further upstream.
MindBridge AI replaces audit sampling with 100% transaction analysis, scoring every entry in a general ledger against patterns from a corpus of 260 billion transactions across 3,000+ ERPs. One published case surfaced $85M in mispostings that sampling missed. The senior associate's job changes from running tests to investigating exceptions.
Thomson Reuters launched CoCounsel Tax and Ready to Review in late 2025. The agentic version is now in 1,300+ firms. Thomson Reuters' 2026 AI in Professional Services Report found a third of tax firms using generative AI and 14% on agentic AI specifically, with 63% planning or considering it. The tool reads a return, flags exceptions for partner review, and drafts the advisory memo. The partner reviews exceptions, not the return.
None of these tools eliminates the partner. They eliminate the work between the staff and the partner. That is what changes the leverage ratio. That is what justifies the multiple. PE buyers are pricing the firms that have already integrated these tools at a different number than the firms that have not.
Watch year four, not year one
The bear case is real. Xeinadin, Exponent Private Equity's UK roll-up of 122 firms, is reportedly struggling to find a buyer at a 15-16x EBITDA target on a £1B valuation. BDO USA's leadership advised member firms in October 2025 to reject PE money outright. Alan Whitman's abrupt March 2023 exit from Baker Tilly remains the clearest cautionary tale about scaling professional services under PE pressure. CPA Practice Advisor's November 2025 piece on hidden risks flagged three-layered noncompetes, 90% client-retention clawbacks, and earn-out terms that can erase 20% of headline valuation if synergy targets miss.
Citrin Cooperman is the bull-case proof point. Xeinadin is the early bear-case proof point. Both get clearer over the next 18 months as more 2021-2022 platforms hit their four-year mark and either flip, recapitalize, or stall.
If you run a $50M firm, the KPIs to watch are not deal volume. They are revenue per partner, advisory mix as a percentage of total revenue, senior-associate utilization, and the integration cadence at the platforms you compete with for talent. Those four numbers tell you whether the 14x is sustaining or compressing back to 10x. They also tell you what your own firm is worth if you ran the same playbook on your balance sheet.
What this means for your next 12 months
The conversations we are in right now with managing partners at firms your size are not about whether to take PE money. They are about whether the operational layer PE buyers assume they will build post-close can be built before close, by the partners who actually understand the review work. We build that layer. Fixed price, four weeks, a working tool. If you are 12 months from a PE conversation, the next 30 minutes is worth booking.
Keep Reading
- Why PE Can't Buy Your Law Firm (But Owns Everything Else). Where PE money is and is not landing in legal services, and what the regulatory bypass looks like.
- Why RIA Roll-Ups Will Spend AI Budget on Back Office First. The wealth-management corollary: how PE-backed RIA platforms are spending AI dollars on the operational ratio, not the client-facing tools.